More Info on the Individuals Indicted by the DOJ Around the Use of “Skin Substitutes”

BREAKING NEWS in the DOJ Press Conference! More Skin Substitute / Cellular Tissue Product (CTP) Fraud Indictments

Today the Department of Justice (DOJ) held a press conference which was led by Dr. Mehmet Oz, the Administrator of the Centers for Medicare and Medicaid (CMS) and officials from the DOJ, announcing the results of its 2025 National Health Care Fraud Takedown. The...
Houston Podiatrist and Business Partner Charged with $45 Million in Healthcare Fraud Related to “Skin Substitutes”

Houston Podiatrist and Business Partner Charged with $45 Million in Healthcare Fraud Related to “Skin Substitutes”

The Houston Chronicle has reported that a Houston podiatrist and his business partner have been charged with $45 million in healthcare fraud in relation to the billing of bioengineered skin substitutes  Dr. David Jenson and Nestor Refael Romero Magallanes are...
BREAKING NEWS: Wound Care Company Owners Plead Guilty to $1.2 B in Fraudulent Claims for Amniotic Products and Face Prison

BREAKING NEWS: Wound Care Company Owners Plead Guilty to $1.2 B in Fraudulent Claims for Amniotic Products and Face Prison

Office of Public Affairs | Arizona Couple Pleads Guilty to $1.2B Health Care Fraud | United States Department of Justice The Department of Justice (DOJ) office of public affairs has announced that on October 24, 2024, Alexandra Gehrke pleaded guilty to conspiracy to...
How Much About Access to Care With “Skin Substitutes” is Around Cost (and Will the LCDs Actually Make That Better for Patients)?

How Much About Access to Care With “Skin Substitutes” is Around Cost (and Will the LCDs Actually Make That Better for Patients)?

A lot is being said about the way that the new LCD(s) around Cellular Tissue Products (CTPs) / skin substitutes might impact access to care. A big issue is around product choice and ensuring that there is a large enough suite of covered products from which physicians...
The US Cellular Tissue Product (CTP) / Skin Substitute Market Reached $1.75 Billion in the Third Quarter of 2023, Based on SmartTrak Analysis

The US Cellular Tissue Product (CTP) / Skin Substitute Market Reached $1.75 Billion in the Third Quarter of 2023, Based on SmartTrak Analysis

According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the third quarter of 2024 (Q324), the US Skin Substitute / Cellular Tissue Product (CTP) market reached $1.75 BILLION. That figure is up 64.0% compared to the third quarter of...
Compared to the Third Quarter, the Cellular Tissue Product (CTP) / Skin Substitute Market Grew 64% in the Fourth Quarter of 2024

Compared to the Third Quarter, the Cellular Tissue Product (CTP) / Skin Substitute Market Grew 64% in the Fourth Quarter of 2024

According to data obtained from SmartTrak Medical Device and Wound Market Intelligence, in the fourth quarter of 2024 ( Q424), the US Cellular Tissue Product (CTP) / Skin Substitute market grew 64.0% over the third quarter of 2023 (Q323). Three market leaders combined...